| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 48.8M | 50.8M | 64.5M | 36.6M | Depreciation And Amortization | 170.7M | 184.7M | 189.5M | 199.0M |
Ownership Breakdown
| Insiders10.63% | Institutions87.76% |
| Retail Investors | 1.61 | |
| Insiders | 10.63 | |
| Institutions | 87.76 |
Should you hold on to your RadNet position?
 | By Aina Ster | Macroaxis Story |
More than 88% of RadNet's shares are held by institutional investors. This means that a significant portion of the company's stock is owned by large entities such as mutual funds, pension funds, insurance companies, and investment firms. These organizations manage money for others and often have substantial influence over the companies in which they invest. For a deeper dive into RadNet's ownership structure and to see our latest analysis, you can explore the current ownership details on our website.
Major Takeaways
RadNet Inc, a leader in the Diagnostics & Research industry, offers a compelling investment opportunity with its solid growth metrics. The company's quarterly earnings growth of 24% underscores its robust performance, while an EPS estimate of 0.75 for next year suggests potential for future profitability. With its shares trading around a typical price of 71.96, RadNet stands poised to capitalize on expanding healthcare needs, making it a noteworthy consideration for investors seeking growth in the Health Care sector.Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
Reviewed by Rifka Kats
RadNet Inc, a prominent player in the healthcare sector, is making waves in the Diagnostics & Research industry. With a robust revenue stream of $1.7 billion, the company is well-positioned to capitalize on the growing demand for healthcare services. Despite a modest profit margin of 0.58%, RadNet's strategic focus on innovation and expansion has analysts optimistic about its future prospects. The company's earnings per share (EPS) estimate for the current and next quarter stands at $0.17, reflecting steady growth potential. As a publicly traded entity on the F exchange under the code PQIA, RadNet continues to attract attention from investors looking for opportunities in the healthcare market. With a Wall Street target price of $77.33, RadNet could be a compelling addition to your investment portfolio. Currently, RadNet's price-to-book ratio remains relatively stable compared to last year. Looking ahead to 2024, free cash flow per share is expected to rise to $0.73, while average payables might decrease slightly to just over $3.6 million. With growing interest in the healthcare providers and services sector, RadNet Inc. deserves a closer look. Why do we maintain optimism for a swift recovery? This discussion aims to highlight key factors influencing RadNet's offerings and how these could shape the investment outlook for December.The performance of RadNet Inc in the marketplace will significantly impact your decision to invest in its stock. Revenue growth, profitability, competitive positioning, management quality, and industry trends can influence RadNet's stock prices. When investing in RadNet, there are several factors to consider and potential outcomes to expect. As a company performs well, its stock price may increase, allowing investors to benefit from price appreciation. However, RadNet Stock can experience significant price fluctuations due to market conditions, economic factors, industry trends, or company-specific news. This is why investing in stocks such as RadNet carries risks, including the potential for capital loss. Stock prices can decline, and investors may incur losses if they sell shares at a lower price than their initial investment.
How important is RadNet's Liquidity
RadNet financial leverage refers to using borrowed capital as a funding source to finance RadNet Inc ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. RadNet financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to RadNet's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of RadNet's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the breakdown between RadNet's total debt and its cash.
What do experts say about RadNet?
Stock analysis is a method for investors and traders to make buying and selling decisions. By studying and evaluating past and current data, investors and traders attempt to gain an edge in the markets by making informed decisions.
Analysis ConsensusBreaking it down a bit more
RadNet owns a total of 73.96 Million outstanding shares. The majority of RadNet Inc outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in RadNet Inc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in RadNet. Please pay attention to any change in the institutional holdings of RadNet Inc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Investing wisely is about seeing potential where others might not. RadNet Inc, a key player in the Diagnostics & Research industry, offers a compelling opportunity for investors looking to tap into the healthcare sector. With a robust quarterly revenue growth of 13.9%, the company demonstrates its ability to expand and adapt in a competitive market. Despite facing a net interest income loss of 63.3 million, RadNet's strategic positioning and a price-to-earnings ratio of 55.56X suggest room for growth and potential upside. As healthcare continues to be a critical focus globally, RadNet's innovative services could make it a smart addition to your investment portfolio..
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Aina Ster do not own shares of RadNet Inc. Please refer to our Terms of Use for any information regarding our disclosure principles.